Filing metadata

Accession number
0001415889-24-001542
Form type
Form 4
Filer
NGM BIOPHARMACEUTICALS INC
CIK
CIK 1426332
Filed
Jan 18, 2024
Reporting period
Jan 16, 2024
Description
Insider transaction

Explore SEC Filings Hub